Literature DB >> 22041852

Subset characterization of myeloid-derived suppressor cells arising during induction of BM chimerism in mice.

A Luyckx1, E Schouppe, O Rutgeerts, C Lenaerts, C Koks, S Fevery, T Devos, D Dierickx, M Waer, J A Van Ginderachter, A D Billiau.   

Abstract

To date, myeloid-derived suppressor cells (MDSC) have been best studied in cancer, where they represent an escape mechanism for immune surveillance. MDSC are now also gaining interest in the context of transplantation. Suppressive CD11b(+) myeloid progenitor cells have been reported to expand endogenously during BM chimerism induction in mice; in particular, in irradiated MHC-matched BM chimeras and in parent-in-F1 BM chimeras. Myeloid cell expansion coincided with a time frame where donor lymphocyte infusion (DLI) therapy-mediated GVL effects without GVHD. Hypothesizing that regulatory myeloid cells may have a role in regulating post-transplant T-cell alloreactivity, we performed a detailed phenotypic and functional characterization of these cells in the parent-in-F1 C57BL/6 → [C57BL/6xDBA2] model. We found that transiently expanding CD11b(+) myeloid progenitor cells comprise the two phenotypically and functionally distinct mononuclear and polymorphonuclear MDSC subsets that were recently described in tumor-bearing mice. Both MDSC subsets suppressed in vitro and in vivo alloreactive T-cell proliferation. Also, both the subsets mediated enhanced in vitro suppression when harvested from chimeras, given a prior in vivo challenge with non-tolerant donor T cells, indicating that allo-activated T cells can activate MDSC in vivo. This study provides the basis to investigate the-potentially beneficial-role of expanding MDSC in influencing the risk of GVHD during chimerism induction.

Entities:  

Mesh:

Year:  2011        PMID: 22041852     DOI: 10.1038/bmt.2011.207

Source DB:  PubMed          Journal:  Bone Marrow Transplant        ISSN: 0268-3369            Impact factor:   5.483


  12 in total

1.  Isolation of myeloid-derived suppressor cells subsets from spleens of orthotopic liver cancer-bearing mice by fluorescent-activated and magnetic-activated cell sorting: similarities and differences.

Authors:  Yaping Xu; Wenxiu Zhao; Duan Wu; Jianfeng Xu; Suqiong Lin; Kai Tang; Zhenyu Yin; Xiaomin Wang
Journal:  Int J Clin Exp Pathol       Date:  2014-10-15

2.  The impact of circulating suppressor cells in multiple myeloma patients on clinical outcome of DLIs.

Authors:  L E Franssen; N W C J van de Donk; M E Emmelot; M W H Roeven; N Schaap; H Dolstra; W Hobo; H M Lokhorst; T Mutis
Journal:  Bone Marrow Transplant       Date:  2015-03-23       Impact factor: 5.483

3.  The MEK inhibitor trametinib separates murine graft-versus-host disease from graft-versus-tumor effects.

Authors:  Hidekazu Itamura; Takero Shindo; Isao Tawara; Yasushi Kubota; Ryusho Kariya; Seiji Okada; Krishna V Komanduri; Shinya Kimura
Journal:  JCI Insight       Date:  2016-07-07

4.  Dynamic change and impact of myeloid-derived suppressor cells in allogeneic bone marrow transplantation in mice.

Authors:  Dapeng Wang; Yu Yu; Kelley Haarberg; Jianing Fu; Kane Kaosaard; Srinivas Nagaraj; Claudio Anasetti; Dmitry Gabrilovich; Xue-Zhong Yu
Journal:  Biol Blood Marrow Transplant       Date:  2013-01-30       Impact factor: 5.742

Review 5.  The Role and Potential Therapeutic Application of Myeloid-Derived Suppressor Cells in Allo- and Autoimmunity.

Authors:  Qi Zhang; Masayuki Fujino; Jinhua Xu; Xiao-kang Li
Journal:  Mediators Inflamm       Date:  2015-05-19       Impact factor: 4.711

6.  Non-traditional CD4+CD25-CD69+ regulatory T cells are correlated to leukemia relapse after allogeneic hematopoietic stem cell transplantation.

Authors:  Xiao-su Zhao; Xu-hua Wang; Xiang-yu Zhao; Ying-jun Chang; Lan-ping Xu; Xiao-hui Zhang; Xiao-jun Huang
Journal:  J Transl Med       Date:  2014-07-01       Impact factor: 5.531

Review 7.  The Effect of Immunosuppressive Drugs on MDSCs in Transplantation.

Authors:  Fan Yang; Yang Li; Qian Zhang; Liang Tan; Longkai Peng; Yong Zhao
Journal:  J Immunol Res       Date:  2018-07-03       Impact factor: 4.818

Review 8.  Myeloid-Derived Suppressor Cells in the Context of Allogeneic Hematopoietic Stem Cell Transplantation.

Authors:  Maud D'Aveni; Anne B Notarantonio; Allan Bertrand; Laura Boulangé; Cécile Pochon; Marie T Rubio
Journal:  Front Immunol       Date:  2020-05-22       Impact factor: 7.561

Review 9.  Myeloid-derived suppressor cells in transplantation: the dawn of cell therapy.

Authors:  Weitao Zhang; Jiawei Li; Guisheng Qi; Guowei Tu; Cheng Yang; Ming Xu
Journal:  J Transl Med       Date:  2018-01-29       Impact factor: 5.531

10.  Peripheral Blood Stem Cell Mobilization in Healthy Donors by Granulocyte Colony-Stimulating Factor Causes Preferential Mobilization of Lymphocyte Subsets.

Authors:  Guro Kristin Melve; Elisabeth Ersvaer; Geir Egil Eide; Einar K Kristoffersen; Øystein Bruserud
Journal:  Front Immunol       Date:  2018-05-02       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.